FABP5P13

Across TCGA pan-cancer cohorts, FABP5P13 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated FABP5P13 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher FABP5P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FABP5P13 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LGG show a favorable association.

LIHC, KICH, and COAD are the cancer types where FABP5P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.343	0.703	<.001	126	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.017	34	view →
STAD	DFS	Quartile	II,III,IV	0.524	0.733	.017	24	view →
HNSC	OS	Tertile	All	0.894	0.666	.015	24	view →
CESC	OS	Tertile	III,IV	0.248	0.684	.035	18	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
PCPG	DFS	Tertile	All	0.554	0.942	.001	15	view →
KIRC	DFS	Tertile	III,IV	0.294	0.494	.010	12	view →
LGG	OS	Tertile	All	0.741	0.431	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

FABP5P13–LIHC (OS)

Open the LIHC breakdown →